13G Filing: Paulson & Co and Synergy Pharmaceuticals Inc. (SGYP)

(a)

[ ]

Broker or dealer registered under Section 15 of the Exchange Act.

(b)

[ ]

Bank as defined in Section 3(a)(6) of the Exchange Act.

(c)

[ ]

Insurance company defined in Section 3(a)(19) of the Exchange Act.

(d)

[ ]

Investment company registered under Section 8 of the Investment Company Act.

(e)

[X]

Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

(f)

[ ]

Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).

(g)

[ ]

Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

(h)

[ ]

Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

(i)

[ ]

Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

(j)

[ ]

Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).

(k)

[ ]

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____